Analysts' Actions: ARO IBM IDCC NTAP THC

TheStreet.com

NEW YORK (TheStreet) -- CHANGE IN RATINGS

Assurant was upgraded at Sterne Agee to neutral. There was lless downward pressure on lender-placed premium rates than originally feared, said Sterne Agee. Price target goes to $51.

Aeropostale was downgraded at Goldman Sachs to sell from neutral. $10 price target. Company is facing increased competition, Goldman said.

Community Health was downgraded at Deutsche Bank to hold from buy. Higher health insurance coverage is largely priced into the sector, Deutsche said.

Health Management was downgraded at Deutsche Bank to hold from buy. Valuation call, following the recent run in the group, Deutsche Bank said.

IBM was upgraded to buy from neutral at UBS. The company is well positioned for the IT-as-a-service transition with a strong strategy and ability to execute, UBS said. Estimates were raised and the price target goes to $235.


IDCC was downgraded to market perform at William Blair. Uncertain timing of future licensing deals, said William Blair.

NetApp was downgraded at UBS from buy to neutral. The company could struggle in the IT-as-a-service era given its narrow product focus, UBS said. Price target was reduced to $37.

Starz Entertainment was upgraded at Lazard Capital Markets to neutral. Resolution of long-term concerns, said Lazard Capital Markets. Catalysts going forward include upside to first-quarter estimates and the potential success of TV show Da Vinci's Demons.


Tenet Healthcare was downgraded at Deutsche Bank to hold from buy. Valuation call, as the sector is up an average of 67% over the past year, Deutsche Bank said.

Targa Resources was downgraded at Morgan Stanley to equal-weight given the recent run in the stock. Price target goes to $70.

STOCK COMMENTS/EPS CHANGES

Advanced Auto Parts estimates were reduced at UBS through 2014 given a weaker-than-expected first quarter. Payroll taxes, delayed tax refunds and weather were all impacts, UBS said.

CSX estimates, price target were raised at Jefferies. Shares are now seen reaching $30. Estimates were also increased, as companies appear to be restocking inventory, Jefferies said. Underperform rating.

Ecolab estimates, price target were increased at Jefferies. Estimates were raised through 2014. Champion deal should add to earnings, Jefferies said. Buy rating and new $93 price target.

Expeditors was cut from the Conviction Buy List at Goldman Sachs. Recent freight indicators have pointed to an uneven recovery, Goldman said. $47 price target.

First Solar price target and estimates were increased at UBS. Estimates were increased through 2014 given increased sales visibility in 2013 after the analyst day, said UBS. Price target goes to $40.

FXCM estimates were reduced at UBS after the company reported results. The company also announced that they sent a letter suggesting the acquisition of GCAP to the board, which will be accretive, UBS said.

Herbalife was downgraded at D.A. Davidson to neutral after KPMG resigned as auditor. The resignation will be disruptive to the stock, D.A. Davidson said. The price target goes to $38.

HMA estimates were reduced at UBS through 2014. Management preannounced first-quarter results that were negatively impacted by several items, UBS said.

Microsoft estimates were reduced at Citigroup through 2014. Reductions reflects a fine from the European Union, said Citigroup. Price target remains $35.

Follow TheStreet on Twitter and become a fan on Facebook.

It's Official: Action Alerts PLUS beats the S&P 500 with Dividends Reinvested! Cramer and Link were up 16.72% in 2012. Were you? See what they are trading for 14-days FREE.

Rates

View Comments (0)